What iShares Biotechnology ETF (IBB) Bought: Gilead Leads on Nov. 13
The fund added $84.9 million in new buying across 232 positions, led by $7.7 million of Gilead Sciences. Related Stocks: IBB , GILD , AMGN , VRTX , REGN , MRNA ,
The fund added $84.9 million in new buying across 232 positions, led by $7.7 million of Gilead Sciences. Related Stocks: IBB , GILD , AMGN , VRTX , REGN , MRNA ,